Page 22 - Healthcare Sector

Alembic Pharma's injectables plant launch may face some delay

Company saw Form 483 with observations issued by US FDA for injectables plant in February

Cred boss, Unacademy co-founder, others back healthcare startup Onsurity

The startup which began its journey last Feb has on boarded 700 SMEs as healthcare partners

Healthcare sector expected to reach $372 billion in 2022: Niti Aayog report

Non-metros (Tier-II and III cities) are expected to recover faster than the metropolitan areas and tier-I cities

TataMD announces partnership with ADL for standardising Covid-19 test kit

TataMD CHECK follows guidelines set by India's drug regulator and ADL has used it for over 10,000 Covid-19 tests, said the Tata group's healthcare venture

Insider alleges Eli Lilly blocked her efforts to sound alarms on drug plant

Lilly is working closely with the FDA to address concerns about the factory,

Cabinet approves reserve fund to manage healthcare schemes in country

PMSSN covers any any programme to achieve India's sustainable development goals and the targets set out in the national health policy

Temasek backs future funds of impact investor LeapFrog with $500 mn

In India, LeapFrog has so far deployed capital across nine companies

Supply challenges for auto-disable syringe needle private hospitals

So far, the syringes were being supplied by the state government

Healthcare startup Innovaccer's valuation crosses $1 bn, joins unicorn club

The new funding round brings the total capital raised by Innovaccer to over $225 million.

Govt working to improve ease of doing biz in pharma sector: Minister

The government is continuously working to reduce regulatory compliance burden on the pharma industry in a bid to improve ease of doing business in the country, Union Minister for Chemicals & Fertilisers D V Sadananda Gowda said on Thursday. Addressing the inaugural session of 'The India Pharma 2021 & India Medical Device 2021' event here, the minister also emphasised that the domestic pharma industry has the capability to achieve the target of USD 130 billion turnover by 2030. "Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the country. Vigorous effort is on to reduce the regulatory compliance burden on the (pharma) industry," Gowda said. Minister of State for Chemicals and Fertilisers Mansukh Mandaviya said that reforms are being undertaken by the government especially in the pharmaceutical sector. "In ease of doing business we have reached 79thposition now from the earlier 145. In the pharma ..

Sun Pharma to launch complete range of generic anti-epilepsy drug

The firm said it plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price

From best to worst: A 2020 winner in stock market is now the biggest loser

Health care is Asia's worst-performing sector this year

MediBuddy raises $20mn funding from India Life Sciences Fund III, others

The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others

India to test efficacy of Covid-19 vaccines against SA, Brazil strains

There are not enough number of cases with the South African and Brazilian strains in the country to check the efficacy

Walmart investors eye push into advertising, healthcare after pandemic boom

Walmart will report fourth-quarter results on Thursday

MediBuddy raises Rs 25 crore debt fund from InnoVen Capital

Digital healthcare platform MediBuddy has raised Rs 25 crore debt fund from InnoVen Capital

It's online all the way: The rise and rise of telemedicine amid Covid-19

Covid-19 gave a huge fillip to remote medical consultations, and the trend is likely to stay

Biocon Biologics inks pact to expand access to its cancer biosimilars

Biocon Biologics is an arm of biotechnology major Biocon

Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton

Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its M&A (merger and acquisition) and global expansion plans

Why pharma stocks are underperforming despite Rs 2.23 trn Budget allocation

Much of the increase in this year's Budget allocation for health and well-being is attributed to expenditure set aside for Covid-19 vaccination